| Female Reproductive System Endometrioid Adenocarcinoma investigated in trials for …INVESTIGATED_IN_TRIALSderived15 of 49show all (up to 200) |
|---|
| → investigated in trials for | Paclitaxelsmall molecule 30 trials (11 active) · roll-up of the cancer and its descendants | — | — | Female Reproductive System Endometrioid Adenocarcinoma | 30 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Carboplatinsmall molecule 23 trials (8 active) · roll-up of the cancer and its descendants | — | — | Female Reproductive System Endometrioid Adenocarcinoma | 23 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Bevacizumabmonoclonal antibody 22 trials (10 active) · roll-up of the cancer and its descendants | — | — | Female Reproductive System Endometrioid Adenocarcinoma | 22 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Doxorubicinsmall molecule 12 trials (6 active) · roll-up of the cancer and its descendants | — | — | Female Reproductive System Endometrioid Adenocarcinoma | 12 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Olaparibsmall molecule 10 trials (8 active) · roll-up of the cancer and its descendants | — | — | Female Reproductive System Endometrioid Adenocarcinoma | 10 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cisplatinsmall molecule 7 trials (1 active) · roll-up of the cancer and its descendants | — | — | Female Reproductive System Endometrioid Adenocarcinoma | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pembrolizumabmonoclonal antibody 7 trials (5 active) · roll-up of the cancer and its descendants | — | — | Female Reproductive System Endometrioid Adenocarcinoma | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Topotecansmall molecule 6 trials (2 active) · roll-up of the cancer and its descendants | — | — | Female Reproductive System Endometrioid Adenocarcinoma | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cediranibsmall molecule 5 trials (5 active) · roll-up of the cancer and its descendants | — | — | Female Reproductive System Endometrioid Adenocarcinoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Gemcitabinesmall molecule 5 trials (4 active) · roll-up of the cancer and its descendants | — | — | Female Reproductive System Endometrioid Adenocarcinoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Letrozolesmall molecule 4 trials (2 active) · roll-up of the cancer and its descendants | — | — | Female Reproductive System Endometrioid Adenocarcinoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Chemotherapy 3 trials (1 active) · roll-up of the cancer and its descendants | — | — | Female Reproductive System Endometrioid Adenocarcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Everolimussmall molecule 3 trials (2 active) · roll-up of the cancer and its descendants | — | — | Female Reproductive System Endometrioid Adenocarcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Filgrastimother 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Female Reproductive System Endometrioid Adenocarcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Atezolizumabmonoclonal antibody 2 trials (2 active) · roll-up of the cancer and its descendants | — | — | Female Reproductive System Endometrioid Adenocarcinoma | 2 | Observed | clinicaltrials | graph → |